Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Amortization of Deferred Charges (2016 - 2018)

IGC Pharma (IGC) has disclosed Amortization of Deferred Charges for 8 consecutive years, with $18000.0 as the latest value for Q3 2018.

  • Quarterly Amortization of Deferred Charges fell 42.68% to $18000.0 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $18000.0 through Mar 2019, changed N/A year-over-year, with the annual reading at $18000.0 for FY2019, N/A changed from the prior year.
  • Amortization of Deferred Charges for Q3 2018 was $18000.0 at IGC Pharma, up from -$115000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $63616.0 in Q3 2014, with the low at -$115000.0 in Q1 2018.
  • Average Amortization of Deferred Charges over 5 years is $27604.3, with a median of $34650.0 recorded in 2016.
  • The sharpest move saw Amortization of Deferred Charges surged 356.95% in 2016, then tumbled 545.72% in 2018.
  • Over 5 years, Amortization of Deferred Charges stood at $55200.0 in 2014, then plummeted by 123.05% to -$12726.0 in 2015, then soared by 356.95% to $32700.0 in 2016, then skyrocketed by 43.73% to $47000.0 in 2017, then crashed by 61.7% to $18000.0 in 2018.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $18000.0, -$115000.0, and $47000.0 for Q3 2018, Q1 2018, and Q4 2017 respectively.